About
Plasmacure is a Dutch MedTech company founded in 2014, focused on innovative treatments for complex and chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers. The company developed the PLASOMA system, a cold plasma-based medical device that accelerates wound healing by applying cold plasma directly to the wound site. This technology is reported to be up to 2.5 times more effective than standard wound care methods. The PLASOMA system enhances healing and helps prevent severe bacterial infections in chronic wounds, aiming to improve patient outcomes and restore mobility and dignity. Plasmacure provides this advanced treatment technology to healthcare providers and clinics, with plans for global expansion. The company has secured significant funding, including a €6 million Series A investment, to support its growth and regulatory efforts in the U.S. market. Plasmacure has received multiple awards for its innovation and is recognized as a promising European MedTech startup.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2013
-
Annual Revenue $3200000
-
Total Funding $7063620
Location
5 Transistorweg, Nijmegen, Gelderland, Netherlands, 6534 AT